American Diabetes Association – Pathways to Stop Diabetes: Accelerator Award (ACE), Visionary Award (VSN)
Internal Deadline: Contact the Office of Research if interested.
External Deadline: July 2, 2018 for January 1, 2019 funding
Award Information: Type: Grant
Estimated Number of Awards: N/A
Anticipated Amount: Accelerator Award: $325,000/year; Visionary Award: $325,000/year in Phase I, $325,000/year in Phase II
Submission Process: PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://app.wizehive.com/webform/USCgrants
Materials to submit:
- Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
- CV – (5 pages maximum)
Link to Award: http://www.diabetes.org/pathway/program/nominations.html
Who May Serve as PI: Accelerator Award: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for, or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Visionary Award: Applicants must hold independent faculty positions and have demonstrated significant productivity in their current field of research. Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetes or diabetes-related research.
Our Vision is simple yet revolutionary: find a new generation of brilliant scientists at the peak of their creativity, then provide them with the freedom, autonomy, and financial and professional resources to set them on the road to breakthrough discoveries.
Pathway to Stop Diabetes is a bold, innovative initiative that is already making strides to radically transform diabetes research.
Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication. Pathway solicits nominations for candidates in all disciplines as applied to diabetes, from medicine, biology and chemistry to engineering, mathematics and physics.
The Pathway program seeks to bring new investigators and new perspectives to diabetes research. Supporting scientists with different backgrounds and experience is critical to achieving that objective.
This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
Awards are designed to support established, experienced investigators with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.
Visit our Institutionally Limited Submission webpage for updates and other announcements.